Electronic supplementary information Stimuli-responsive ... · Nagarjun Narayanaswamy,a Sivakrishna...
Transcript of Electronic supplementary information Stimuli-responsive ... · Nagarjun Narayanaswamy,a Sivakrishna...
1
Electronic supplementary information
Stimuli-responsive colorimetric and NIR fluorescence combination probe for
selective reporting of cellular hydrogen peroxide
Nagarjun Narayanaswamy,a Sivakrishna Narra,
b Raji R. Nair,
c Deepak Kumar Saini,
c Paturu
Kondaiahb and T. Govindaraju*
a
aBioorganic Chemistry Laboratory, New Chemistry Unit, Jawaharlal Nehru Centre for Advanced
Scientific Research, Jakkur P.O., Bengaluru 560064, India.
b,cDepartment of Molecular Reproduction, Development and Genetics, Indian Institute of
Science, Bengaluru 560 012, India.
Electronic Supplementary Material (ESI) for Chemical Science.This journal is © The Royal Society of Chemistry 2016
2
Scheme 1. Synthesis of QCy-BA
Preparation of (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol (1).
BHO OH
HO
MgSO4 / Pinacol
Acetonitrile, Reflux
BO O
HO
1
B
HO
HO OH
MgSO4/Pinacol
Acetonitrile, Reflux
B
HO
OO
NaI/TMSCl
Acetonitrile, 0 oC
B
I
OO
4-hydroxyisophthalaldehydeK2CO3
DMF, RT
O O
O
BO
O
N
S
I
1 2
34
Piperidine
DCM/MeOH Reflux
O
BOH
OH
S
N N
S
I I
QCy-BA
3
To a stirred solution of 4-(hydroxymethyl)phenylboronic acid (0.4 g, 2.63 mmol) in acetonitrile
(15 mL), MgSO4 (3 g) and pinacol (0.37 g, 3.15 mmol) were added. The reaction mixture was
heated up to 80 °C and allowed to reflux for 24 h. After completion of the reaction, solvent was
evaporated under vacuum. The crude mixture was dissolved in dichloromethane and filtered. The
obtained product (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol (1) was used
for further reaction without purification.
Preparation of 2-(4-(iodomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2).
To a stirred solution of (4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol (1)
(0.55 g, 2.35 mmol) in acetonitrile (20 mL), sodium iodide (1.1 g, 7.05 mmol) and Trimethylsilyl
chloride (0.65 mL, 7.05 mmol) were added at 0 °C. The reaction mixture was allowed to stir at
room temperature for 1 h. After completion of the reaction solvent was evaporated under
vacuum. The crude product was dissolved in saturated solution of Na2S2O3 to quench the
unreacted iodide and the product was extracted with dichloromethane. The crude product was
purified by column chromatography on silica gel using ethyl acetate\hexane (5:95) as an eluent
to give product 2-(4-(iodomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2) in
excellent yield (90%). 1H NMR (400 MHz, CDCl3) δppm 7.73 (d, J = 8 Hz, 2H), 7.37 (d, J = 8
BO O
HO
NaI/TMsCl
Acetonitrile, 0 °C
BO O
I
2
4
Hz, 2H), 4.45 (s, 2H), 1.34 (s, 12H). 13
C NMR (100 MHz, CDCl3) δppm 142.3, 135.3, 128.0, 24.9,
5.4
Preparation of 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzyloxy)isophthalaldehyde (3).
To a stirred solution of 4-hydroxyisipthaladehyde (0.11 g, 0.73 mmol) in DMF (5 mL), K2CO3
(0.3 g, 2.17 mmol) was added and allowed to stir for 20 min. After 20 min, 2-(4-
(iodomethyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2) (0.3 g, 0.87 mmol) was added
and stirred overnight at room temperature (RT). The completion of reaction was monitored by
TLC. After completion of the reaction, solvent was evaporated and product was extracted with
diethylether (3×100 mL). The crude product was purified by column chromatography on silica
gel using ethyl acetate\hexane (20:80) as an eluent to obtained compound 3 in good yield (60%).
1H NMR (400 MHz, CDCl3) δppm 10.56 (s, 1H), 9.95 (s, 1H), 8.35 (d, J = 2.4 Hz, 1H), 8.08 (dd, J
= 2 Hz, 8.8 Hz, 1H), 7.86 (d, J = 8 Hz, 2H), 7.44 (d, J = 8 Hz, 2H), 7.17 (d, J = 8 Hz, 1H), 5.32
(s, 2H), 1.35 (s, 12H). 13
C NMR (100 MHz, CDCl3) δppm 190.1, 188.5, 164.9, 137.9, 135.5,
135.3, 131.9, 129.9, 126.5, 125.2, 113.7, 84.0, 71.0, 24.9
BO O
I
DMF, RT
K2CO3O O
O O
O
OH
BO
O
32
5
Preparation of QCy-BA.
DCM / MeOH
Piperidine, Reflux QCy-BAO O
O
BO
O
N
S
I
3 4
S
N N
S
O
BOH
OH
I I
To a stirred solution of compound (4)1 (80 mg, 0.27 mmol) in methanol (10 mL) and
dichloromethane (5 mL), piperidine (8 µL) was added and allowed to stir for 10 minutes. After
10 min, 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyloxy)isophthalaldehyde (3) (45
mg, 0.12 mmol) in DCM (2 mL) was added and heated up to 50 °C for 3 h. After the completion
of reaction solvent was evaporated. The crude brown color solid was washed with diethylether
(50 mL) to remove the unreacted starting materials. The brown solid was dissolved in
acetonitrile/water mixture and purified by reverse phase HPLC using 0.1% trifluoroacetic acid
(TFA) in water/acetonitrile (50-100%) as a mobile phase to obtained boronic acid conjugate
(QCy-BA) in moderate yield 30%. 1H-NMR (400 MHz, DMSO-d6) δppm 8.69 (d, J = 2Hz, 1H),
8.44 (ddd, J = 2.8 Hz, J = 4.0 Hz, J = 7.6 Hz, 2H), 8.34-8.25 (m, 4H), 8.21 (d, J = 4.2 Hz, 1H),
8.16 (d, J = 12.4 Hz, 1H), 8.10 (d, J = 8.2 Hz, 1H), 7.92-7.88 (m, 4H), 7.81 (td, J = 0.8 Hz, J =
7.6 Hz, 2H ), 7.56 (dd, J = 4 Hz, J = 8.4 Hz, 3H), 5.48 (s, 2H), 4.39 (s, 3H), 4.25 (s, 3H). 13
C-
NMR (100 MHz, DMSO-d6) δppm 171.9, 171.8, 160.6, 158.3, 158.0, 147.0, 142.1, 142.0, 141.6,
137.5, 135.0, 134.5, 132.3, 129.5, 129.4, 128.6, 128.4, 127.9, 127.8, 127.3, 127.0, 124.3, 124.2,
123.1, 118.1, 117.0, 116.9, 115.6, 115.1, 114.4, 113.0, 71.0, 36.4, 36.2. HRMS (ESI-MS): found
288.0875, calcd m/z = 288.0851 for C33H29BN2O3S2 [M-2I]2+
.
6
Fig. S1 (a) Absorption spectra of QCy-BA (5 M) in presence of H2O2 (1 mM). (b) Emission
spectra of QCy-BA (5 M) in presence of H2O2 (1 mM) in PBS-buffer solution as a function of
time.
300 400 500 600 700
0.10
0.15
0.20
Ab
so
rba
nc
e (
a.u
)
Wavelength (nm)
QCy-BA+H2O
2
a b
500 550 600 650 700 750 800 8500
3
6
9
12
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Wavelength (nm)
QCy-BA+H2O
2
7
Fig. S2 Mechanism of selective reaction of hydrogen peroxide-assisted oxidation of boronic acid
in QCy-BA followed by hydrolysis and 1,6-elimination of p-quinone methide moiety to release
DNA minor groove binder QCy-DT.2
S
N N
S
QCy-BA
O
BHO
OH
O O
H
S
N N
S
O
BHO
OHO
OH
S
N N
S
O
OB
HO
OH
S
N N
S
O
O
S
N N
S
O
OQCy-DT
p-Quinone-methide
1, 6-elimination
Nucleophilic migration
Nucleophilic attack
Tetrahedral boronate complex
Hydrolysis
8
Detection limit of H2O2 in presence of QCy-BA. Concentration dependent studies were
performed using microplate reader. In the well-plates, first we have taken QCy-BA (5 M) in
buffer solution, then we added increasing concentration of H2O2 from 0 to 100 M. Upon
excitation at 400 nm, we have collected the emission at 565 nm as function time after addition of
H2O2.The fluorescence intensity at 565 nm was plotted as a function of concentration of
hydrogen peroxide and each experiment was done in triplicates.
Fig. S3 Plot of the fluorescence intensity at 565 nm against the concentration of [H2O2] PBS-
buffer solution. Each data point was acquired after addition H2O2 at 25 °C. The detection limit
(5.3 μM) was calculated with 3σ/k; where σ is the standard deviation of blank measurement, k is
the slop (-0.30).
Detection Limit
0 5 10 15 2018
20
22
24
26
28
H2O2 (M)
Flu
ore
scen
ce i
nte
nsit
y(a
.u)
9
Fig. S4 (a) Absorption spectra of QCy-BA (2 M) in presence of Drew-AT (2 M). (b)
Emission spectra of QCy-BA (2 M) in presence of Drew-AT (2 M) in PBS-buffer solution.
Fig. S5 (a) Fluorescence response of the combination probe QCy-BA⊂Drew-AT (2 M) in
presence of H2O2 upon excitation with wavelength corresponding to isosbestic point at 456 nm.
Inset: Fluorescence intensity ratio of I650/I500 as function of time (0 to 80 min). (b) Fluorescence
response of the combination probe QCy-BA⊂Drew-AT (2 M) with increasing concentration of
H2O2 from 0 to 200 M upon excitation at 456 nm. Inset: Fluorescence intensity ratio of I650/I500
as function of concentration of H2O2.
300 400 500 600 7000.0
0.1
0.2
0.3
0.4A
bs
orb
an
ce
(a
.u)
Wavelength (nm)
QCy-BA
QCy-BA+Drew-ATa
500 550 600 650 700 750 8000
5
10
15
20
25
30
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Wavelength (nm)
QCy-BA
QCy-BA + Drew-ATb
500 550 600 650 700 750 800 850 9000
20
40
60
80
100
120
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Wavelength (nm)
H2O
2
500 550 600 650 700 750 800 850 9000
20
40
60
80
100
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Wavelength (nm)
Time
0 20 40 60 800
5
10
15
20
25
30
I 65
0/I
50
0
Time (min)
a b
0 50 100 150 2000
10
20
30
40
I 65
0/I
50
0Conc. of H
2O
2 (M)
10
Fig. S6 Fluorescence response of combination probe QCy-BA⊂Drew-AT (2 M) to various
ROS at individual concentrations of 100 µM upon excitation at 564 nm.
Fig. S7 Time-dependent fluorescence spectra of QCy-BA (2 M) in presence of Drew-AT (2
M) after the addition of H2O2 (100 M) upon excitation at 564 nm.
0
50
100
150
200
250
300
Flu
ore
scen
ce in
ten
sit
y
at
650 n
m (
a.u
)
0 40 80 120 160 200 240
10
20
30
40
50
60
70
80 QCy-BA + Drew-AT + H
2O
2 (100 M)
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Time (min)
11
Fig. S8 Plot of ln(F∞–F) of combination probe QCy-BA⊂Drew-AT (2 M) as a functions of
time at 650 nm upon addition of H2O2 (1 mM), where F∞ and F are the fluorescence intensities at
650 nm at time t∞ (= 60 min) and t, respectively. The kobs calculated from the slope of this plot is
1.04 × 10-3
s-1
.
Fig. S9 (a) Fluorescence spectra of combination probe QCy-BA⊂Drew-AT in presence of GOx
(4 U/mL) and glucose (1 mM) with time, upon excitation at 400 nm. (b) Plot of fluorescence
intensity of combination probe QCy-BA⊂Drew-AT at 650 nm as function of time, in presence
of GOx (4 U/mL) with increasing concentration of glucose from 0 to 1 mM upon excitation at
564 nm.
0 800 1600 2400 32000.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
QCy-BA+Drew-AT
Time (sec)
ln(F
∞-F
)
500 550 600 650 700 750 800 8500
6
12
18
24
30
36
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Wavelength (nm)
0 20 40 60 80 100
10
20
30
40
50
60
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Time (min)
Glucose
a b
12
Fig. S10 The plot of the fluorescence intensity of combination probe QCy-BA⊂Drew-AT in the
presence of GOx (4 U/mL) against the concentration of glucose at 650 nm. Each data point was
acquired 1 h after addition of glucose and GOx at 25 °C. The detection limit (6.11 μM) was
calculated by 3σ/k, where σ is the standard deviation of blank measurement and k is the slop
(0.12).
Fig. S11 Plot of ln(F∞–F) of combination probe QCy-BA⊂Drew-AT in presence of GOx (4
U/mL) as a functions of time at 650 nm upon addition of glucose (1 mM), where F∞ and F are the
fluorescence intensities at 650 nm at time t∞ (= 100 min) and t, respectively. The kobs calculated
from the slope of this plot is 6.87 × 10-4
s-1
.
Detection Limit
0 50 100 150 2000
10
20
30
40
Glucose (M)
Flu
ore
sc
en
ce
in
ten
sit
y(a
.u)
0 1000 2000 3000 4000 5000 60000.0
0.5
1.0
1.5
2.0
2.5
3.0
3.5
4.0
QCy-BA + Drew-AT + GOx + Glucose
Time (sec)
ln(F
∞-F
)
13
Fig. S12 (a) Schematic diagram represents the catalase activity in presence of H2O2 and
combination probe QCy-BA⊂Drew-AT. (b) Fluorescence intensity of QCy-BA at 565 nm.
Where Q: QCy-BA, QH: QCy-BA+H2O2, QHD: QCy-BA+H2O2+Drew-AT, QCH: QCy-
BA+Catalase+H2O2, QCHD: QCy-BA+Catalase+H2O2+Drew-AT. (c) Time dependent
fluorescence of combination probe QCy-BA⊂Drew-AT in presence and absence of catalase
upon addition of H2O2 (1 mM) upon excitation at 564 nm.
0
25
50
75
100
125
Q QH QHD QCH QCHD
Rela
tive i
nte
nsit
y (
a.u
)
0 20 40 60 80 100 1200
10
20
30
40
50
60
70
80
Flu
ore
sc
en
ce
in
ten
sit
y (
a.u
)
Time (min)
QCy-BA+Catalase+H2O
2+Drew-AT
QCy-BA+H2O
2+Drew-AT
b c
a
H2O2
H2O O2+ Catalase
X Drew-AT
QCy-DT⊂Drew-AT
QCy-BA
o
14
Fig. S13 Dose dependent cell viability of HeLa cells by taking 0.0-25 µM of probe QCy-BA for
24 h. Error bars represent ±standard deviation.
Fig. S14 (a) Flow cytometry plots of HeLa cells in the absence and presence of QCy-BA (5
M). (b) FACS-analysis shows the PerCP mean fluorescence intensity in HeLa cells in presence
of QCy-BA (5 M).
00
20
40
60
80
100
120
0.0 3.125 6.25 12.5 25 50
Conc. of QCy-BA (M)
% C
ell V
iab
ilit
y
00
1000
2000
3000
4000
Cells Cells +QCy-BAFlu
ore
sc
en
ce
in
ten
sit
y(a
.u)
ba
15
Fig. S15 (a) Flow cytometry plots of probe QCy-BA (5 M) treated HeLa cells in the presence
of H2O2 (100 M) and NAC (8 mM). (b) Flow cytometry plots of probe QCy-BA (5 M) treated
HeLa cells in the presence of epidermal growth factor (EGF) (50 ng/mL) and NAC (8 mM).
1
2
34 1. Cells
2. QCy-BA
3. QCy-BA+ NAC +EGF
4. QCy-BA +EGF
Co
un
t
PerCP-A
b
1. QCy-BA
2. QCy-BA +H2O2
3. QCy-BA + NAC
4. QCy-BA + NAC + H2O2
a
16
Fig. S16 H2O2 detection in attached live HeLa cells using DCFDA after treatment with BrdU
(100 µM) and doxorubicin (0.1 µM) for 48 h. Fold change of fluorescence per cell is normalized
to 1 for control cells (n=3).
Table S1. Comparison of probe QCy-BA with Naphtho-Peroxyfluor-1 (NPF-1).
a A. E. Albers, B. C. Dickinson, E. W. Miller and C. J. Chang, Bioorg. Med. Chem. Lett., 2008, 18, 5948–5950.
b
Present work.
0
2
4
6
8
Control BrdU Dox
Fo
ld c
han
ge o
f fl
uo
rescen
ce
per
cell
Property Naphtho-Peroxyfluor-1 (NPF1) a QCy-BA b
Synthesis Metal-catalyst required Metal-catalyst not required
Solubility DMSO Water
Stokes shift ∆λmax = ~62 nm ∆λmax = ~280 nm
Detection Fluorescence Fluorescence as well as naked eye
Incubation time ~60-120 min ~15-30 min
Concentration required for cell
imaging
~20 µM ~5 µM
17
Reference
1. N. Narayanaswamy, M. Kumar, S. Das, R. Sharma, P. K. Samanta, S. K. Pati, S. K. Dhar, T.
K. Kundu and T. Govindaraju. Sci. Rep., 2014, 4, 6476.
2. A. R. Lippert, G. C. Van de Bittner and C. J. Chang, Acc. Chem. Res., 2011, 44, 793–804.
18
1H NMR spectrum of compound 2
13C NMR spectrum of Compound 2
B
I
OO
B
I
OO
19
1H NMR spectrum of Compound 3
13C NMR spectrum of Compound 3
O O
O
BO
O
O O
O
BO
O
20
1H NMR spectrum of QCy-BA
13C NMR spectrum of QCy-BA
O
BOH
OH
S
N N
S
I I
O
BOH
OH
S
N N
S
I I
21
HPLC trace of QCy-BA
HRMS mass data of QCy-BA
0.0 2.5 5.0 7.5 10.0 min
0
100
200
300
400mAU
O
BOH
OH
S
N N
S
O
BOH
OH
S
N N
S
[M-2I]2+
Exact Mass: 288.0851